Mavoglurant-impurities | Pharmaffiliates

Mavoglurant

Mavoglurant developmental code name AFQ-056 is an experimental drug candidate for the treatment of fragile X syndrome. Reference standards of Mavoglurant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Mavoglurant - API Standards
    [catalogue_number] => PA 13 3110000
    [category_ids] => ,79,71,78,70,82,75,
    [chemical_name] => 
    [weight] => 313.4
    [form] => C19H23NO3
    [cas] => 543906-09-8
    [pslug] => 543906-09-8-mavoglurant-api-standards-pa133110000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 13 3110000

Mavoglurant - API Standards


  • Catalogue No.:PA 13 3110000

  • CAS :

    543906-09-8

  • Molecular Formula : C19H23NO3

  • Molecular Weight : 313.4